12 studies found for:    "Columbia University" AND "HCV" | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
Condition: Substance-related Disorders
Interventions: Behavioral: On-site bundled rapid HIV/HCV testing;   Behavioral: Standard of care (SOC)
2 Not yet recruiting Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre or Post Liver Transplant
Conditions: HIV;   Hepatitis C;   Cirrhosis
Intervention: Drug: Harvoni
3 Recruiting Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant
Condition: Hepatitis C
Interventions: Drug: Rifaximin;   Drug: Placebo
4 Not yet recruiting Evaluating a Microfinance Intervention for Vulnerable Women in Kazakhstan
Condition: HIV/AIDS and Infections
Interventions: Behavioral: Microfinance intervention (MF);   Behavioral: HIV risk reduction (HIVRR)
5 Recruiting An Observational Study of Hepatitis C Virus in Pregnancy
Condition: Hepatitis C
6 Recruiting Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Conditions: Hepatitis C Infection;   Viruses;   Hepatocellular Carcinoma;   Hepatitis, Viral, Human;   Liver Cirrhosis
Intervention: Biological: Civacir® 10%
7 Recruiting HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Condition: Hepatitis C
8 Recruiting A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
Conditions: Liver Fibrosis;   Hepatic Fibrosis;   Liver Cirrhosis;   Hepatic Cirrhosis
Interventions: Drug: IDN-6556;   Drug: Placebo
9 Recruiting Everolimus Post Orthotopic Liver Transplant
Condition: Orthotopic Liver Transplant
Interventions: Drug: Everolimus;   Drug: Standard Tacrolimus
10 Recruiting Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
11 Available A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Daclatasvir (BMS-790052);   Drug: Sofosbuvir
12 Recruiting S1204, Viral Screening in Newly Diagnosed Cancer Patients
Condition: Cancer

Indicates status has not been verified in more than two years